Obesity Featured Articles
-
Patient And Public Involvement – Stranded On The Adoption Curve?
4/29/2024
By elucidating the barriers impeding progress on the PPI adoption curve and offering actionable insights, this article aims to catalyze renewed efforts toward harnessing the full potential of patient engagement in shaping the future of healthcare delivery.
-
Cancer Treatment: Advances In The 20th And 21st Centuries
4/29/2024
This exploration not only illuminates the remarkable strides made in combating cancer but also underscores the pivotal role of cutting-edge technologies in shaping the trajectory of oncological care.
-
6 Decades Of Impact: DIA’s Global Journey
4/29/2024
By embracing its foundational pillars, learn how DIA continues to address ongoing challenges in drug information and healthcare as it enters its seventh decade in the industry.
-
What Can Digital Patient Twins Do For Clinical Research?
4/29/2024
Digital patient twins have the potential to vastly improve our current healthcare systems by offering personalized therapeutics, enhanced health monitoring, and streamlined pharmaceutical manufacturing, including clinical trials.
-
The Relevance Of ePROs In Early Phase Clinical Trials
4/26/2024
Examine how integrating electronic Patient Reported Outcomes (ePROs) in early clinical research not only enhances understanding of the drug's effects but also amplifies its market value.
-
What To Expect From An FDA Inspection
4/26/2024
Former FDA inspector turned regulatory consultant, Patrick Stone, gives some valuable insights to what to expect when the FDA comes knocking at your clinical trial site. Here's a hint: make sure you PI knows the difference between presiding over and overseeing a study.
-
Fortifying The 3 Cs With Strategic Approaches And Tools
4/25/2024
In part two of this series, the authors continue the discussion by identifying specific tools and strategies that companies can use to improve communication and collaboration.
-
Assessing The 3Cs: Does Your Organization Have The Foundation For Clinical Trial Success?
4/25/2024
In part one of this series on exploring the importance of culture, communication, and collaboration, the authors discuss the makings of a strong company foundation and offer an assessment plan meant to reveal strengths and weaknesses in those three areas.
-
Validating A Better ALS Biomarker With Coya’s Fred Grossman
4/24/2024
Coya Therapeutics President and CMO Fred Grossman, DO, FAPA discusses a potential new biomarker for ALS — 4-HNE, an oxidative stress biomarker — and how it could be more effective than the current standard, NfL.
-
For Veteran PI, Research Requires Motivation, Dedication, And CRO Support
4/23/2024
Principal investigator Dr. Luke Twelves discusses how he remained motivated to continue conducting trials and shares insights into what he thinks will inspire others to do the same.